We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Nutrients Stop Cancer Metastasis

By Biotechdaily staff writers
Posted on 09 Nov 2005
Cancer metastasis can be stopped in mice by using a combination of nutrients, according to a study presented at the annual combined meeting of the World Congress on Advances in Oncology and the International Symposium on Molecular Medicine, held in Crete (Greece) in October 2005.

The study documents that vitamin C used in combination with the amino acids L-lysine, L-proline, and a polyphenol fraction of green tea known as Epigallocatechin Gallate (EGCG) not only killed cancer cells and significantly limited tumor growth and its infiltration by blood vessels, but also completely stopped the invasion and spread of more than two dozen cancer cell types. More...
The study was conducted by Dr. Rath and colleagues of the Dr. Rath Research Institute (Santa Clara, CA, USA), who note that this marks the first time nutrient synergy has been shown to stop the spread of metastasis in the body of a living organism.

The study results came on the heels of a recent study by the U.S. National Institutes of Health (Bethesda, MD, USA), which strongly confirmed that vitamin C has the potential to fight cancer when injected intravenously in high dosages.

"A growing number of researchers confirm that Dr. Rath was right, and nutrients, especially when used in a synergy, can control all critical stages of cancer,” said Aleksandra Niedzwiecki, Ph.D., director of the institute.

The conference was organized by Demetrios A. Spandidos, professor of virology at the Medical School, University of Crete, who personally invited the Dr. Rath Research Institute team to the event. The institute is calling for a radical change in the therapeutic approach to cancer, one that takes advantage of new natural approaches.





Related Links:
Dr. Rath Research Institute

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.